Location History:
- Boston, MA (US) (2021)
- Chestnut Hill, MA (US) (2022)
Company Filing History:
Years Active: 2021-2022
Title: Innovations by Jing Ni in Cancer Treatment
Introduction
Jing Ni is an accomplished inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of cancer treatment, particularly in addressing brain metastases. With a total of 2 patents, his work focuses on innovative therapeutic methods that combine various agents to enhance treatment efficacy.
Latest Patents
Jing Ni's latest patents include:
1. **Methods for treating brain metastases using combinations of anti-PI3K and anti-mTOR agents** - This invention relates to methods of treating brain metastases using synergistic combinations of anti-PI3K and anti-mTOR therapies. It has been determined that blocking PI3K and mTOR provides therapeutic benefits for treating brain metastases.
2. **Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders** - This invention involves the use of pyrimido-diazepinone compounds that can modulate protein kinases such as PI3K-γ and PI3K-δ. These compounds are utilized in the treatment of various diseases, disorders, or conditions.
Career Highlights
Jing Ni is currently associated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in cancer therapies. His work is pivotal in developing new treatment strategies that can significantly improve patient outcomes.
Collaborations
Some of his notable coworkers include Jean Zhao and Shaozhen Xie, who contribute to the collaborative efforts in research and development at the institute.
Conclusion
Jing Ni's innovative work in cancer treatment exemplifies the impact of research and invention in the medical field. His patents reflect a commitment to improving therapeutic options for patients with brain metastases.